# Sustained Propranolol Use and Site-Specific All-Cause Mortality after Cancer Diagnosis: A Nationwide Taiwan Cohort Study

_Oncology Research · Paul J. Chen, Jung-Ju Lin, Wei-Lin Hsu et al. · 2026_

Canonical: https://diginpl.com/books/paper-or-2026-086291
Last updated: 2026-10-02

## Quick facts

- **Author:** Paul J. Chen; Jung-Ju Lin; Wei-Lin Hsu; Der-Cherng Chen; Yu-Hsiang Lin; Chien-Tung Yang; Chao-Hsuan Chen; Yu-Chung Juan ([Crossref](https://doi.org/10.32604/or.2026.086291))
- **Published:** 2026 ([Crossref](https://doi.org/10.32604/or.2026.086291))
- **Publisher:** Tech Science Press ([Crossref](https://doi.org/10.32604/or.2026.086291))
- **Journal:** Oncology Research ([Crossref](https://doi.org/10.32604/or.2026.086291))
- **DOI:** 10.32604/or.2026.086291 ([Crossref](https://doi.org/10.32604/or.2026.086291))

## Questions

**Who wrote Sustained Propranolol Use and Site-Specific All-Cause Mortality after Cancer Diagnosis: A Nationwide Taiwan Cohort Study?**  
Sustained Propranolol Use and Site-Specific All-Cause Mortality after Cancer Diagnosis: A Nationwide Taiwan Cohort Study was written by Paul J. Chen, Jung-Ju Lin, Wei-Lin Hsu, Der-Cherng Chen.

**When was Sustained Propranolol Use and Site-Specific All-Cause Mortality after Cancer Diagnosis: A Nationwide Taiwan Cohort Study first published?**  
Sustained Propranolol Use and Site-Specific All-Cause Mortality after Cancer Diagnosis: A Nationwide Taiwan Cohort Study was first published in 2026.

## Sources

- [Publisher record (DOI, via Crossref)](https://doi.org/10.32604/or.2026.086291)

## Licence and attribution

Open-access publication. Read it free at the publisher: https://doi.org/10.32604/or.2026.086291.

## Cite this page

"Sustained Propranolol Use and Site-Specific All-Cause Mortality after Cancer Diagnosis: A Nationwide Taiwan Cohort Study". DigiNepal. Last updated 2 October 2026. https://diginpl.com/books/paper-or-2026-086291. Retrieved 14 November 2026.